Lv3
324 积分 2021-05-13 加入
Discovery of the First Clinical Protein Degrader for the Treatment of Autoimmune Indications: Orally Bioavailable and Selective IRAK4 Degrader KT-474
19天前
已完结
Design, Synthesis, and Evaluation of Nucleolin-Bridged, MDM2-Recruiting IRAK4 Degraders for the Treatment of Autoimmune Diseases
19天前
已完结
Design of optimized epigenetic regulators for durable gene silencing with application to PCSK9 in nonhuman primates
29天前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
In vivo CAR-T therapy: recent progress and future directions
1个月前
已完结
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
5个月前
已完结
IL-10-expressing CAR-T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
5个月前
已完结
Regulatory T cells 1-4 expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus
6个月前
已完结
Targeted Delivery of Circular Single-Stranded DNA Encoding IL-12 for the Treatment of Triple-Negative Breast Cancer
6个月前
已完结